BNP PARIBAS FINANCIAL MARKETS - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$207,466,000
+22.1%
5,800
-11.2%
0.00%
Q3 2014$169,884,000
+2115.5%
6,534
+2716.4%
0.00%
Q2 2014$7,668,000
-94.0%
232
-95.2%
0.00%
Q1 2014$127,989,000
+223.8%
4,808
+269.3%
0.00%
Q4 2013$39,529,000
-95.5%
1,302
-95.3%
0.00%
-100.0%
Q3 2013$876,556,000
+65.5%
27,556
-21.4%
0.00%
Q2 2013$529,648,00035,0760.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Century Capital Management, LLC 97,360$3,483,0000.10%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 387,600$17,799,0000.02%
View complete list of NPS PHARMACEUTICALS INC shareholders